Doctor of Osteopathy Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Ross Brockman

Pediatric Dermatology Puyallup, WA Doctor of Osteopathy

NPI 1568842185 CMS profile 1370799

1703 S Meridian Ste 101, Puyallup, WA 98371

Open in the dashboard

General payments

$108,981

222 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ross Brockman of Puyallup, WA is reported in the CMS Open Payments database as having received $108,981 across 222 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Pediatric Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $43,765 75
2024 General $48,815 72
2023 General $13,179 48
2022 General $3,223 27

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ross Brockman
  • Pediatric Dermatology median
  • Middle half of Pediatric Dermatology
  • National median

In program year 2025, general payments to Ross Brockman were reported at $43,765. Among 172 Pediatric Dermatology profiles paid that year, the median was $302 and the middle half received between $110 and $2,128.

Show as a table
Year Ross Brockman Pediatric Dermatology median Middle half National median
2019 $0 $280 $89–$1,853 $163
2020 $0 $263 $71–$2,376 $114
2021 $0 $227 $69–$1,800 $132
2022 $3,223 $289 $69–$1,516 $149
2023 $13,179 $537 $114–$3,255 $160
2024 $48,815 $437 $114–$2,693 $164
2025 $43,765 $302 $110–$2,128 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Genzyme Corporation $74,133 72 payments
  2. Regeneron Healthcare Solutions, Inc. $32,743 69 payments
  3. AbbVie, Inc. $460 9 payments
  4. Incyte Corporation $335 11 payments
  5. Pfizer Inc. $196 2 payments
  6. Janssen Biotech, Inc. $196 13 payments
  7. Sun Pharmaceutical Industries Inc. $192 6 payments
  8. Novartis Pharmaceuticals Corporation $140 7 payments
  9. Lilly USA, LLC $134 8 payments
  10. Amgen Inc. $129 5 payments
  11. Other $323 20 payments

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $96,714 28 payments
  2. Travel and Lodging $5,183 27 payments
  3. Food and Beverage $4,628 163 payments
  4. Consulting Fee $2,264 1 payment
  5. Education $192 3 payments
Products named General payments · program years 2022–2025
  1. DUPIXENT Immunology $76,866 81 payments
  2. DUPIXENT Inflammation And Immunology $17,126 41 payments
  3. DUPIXENT Immunology And Inflammation $15,505 27 payments
  4. OPZELURA $335 11 payments
  5. LITFULO $196 2 payments
  6. TREMFYA $196 13 payments
  7. ILUMYA $192 6 payments
  8. RINVOQ $174 5 payments
  9. Otezla $129 5 payments
  10. TALTZ $116 7 payments
  11. Other $701 35 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

222 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Dermatology in Washington

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record